Immuron AGM Seeks 10% Extra Placement Capacity; Contested Board Seat on Ballot

summarizeSummary

Immuron's AGM notice asks shareholders to approve an extra 10% placement capacity (up to ~32.3M shares) and to renew its Omnibus Incentive Plan with a higher 12.5% issuance cap, while a shareholder-nominated director the Board opposes is also on the ballot.

check_boxKey Events · Corporate Governance and Compliance · IMRN

• AGM Set for 18 November 2026

  Immuron will hold its 2026 Annual General Meeting on 18 November 2026 at 2:00 pm AEDT in Carlton South, Victoria, with five resolutions on the ballot.

• Extra 10% Placement Capacity Sought

  Resolution 3 is a special resolution seeking an additional 10% placement facility under ASX Listing Rule 7.1A, on top of the existing 15% capacity under Listing Rule 7.1. No shares have been issued under it; it is authorization only.

• Potential Dilution of ~32.3M Shares

  The filing's illustration shows 322,848,081 shares on issue and a maximum 10% facility of 32,284,808 shares, raising A$645,696 at A$0.020, A$1,291,392 at A$0.040, or A$1,937,088 at A$0.060. The filing notes placement securities may be issued at a discount to market.

• Contested Board Seat on Ballot

  Shareholder-nominated candidate Param Lally, assessed by the Board as independent, stands for election as a Non-Executive Director; the Board recommends shareholders vote AGAINST Resolution 5.

auto_awesomeAnalysis · IMRN · Life Sciences

At Immuron's annual meeting, shareholders are being asked to grant an additional 10% placement facility under ASX Listing Rule 7.1A, on top of the existing 15% capacity under Listing Rule 7.1. That is permission to issue up to roughly 32.3 million new shares (10% of the 322,848,081 shares on issue) over the next 12 months without further shareholder approval — at the A$0.040 reference price used in the filing, that would raise about A$1.29 million, and the filing itself notes placement securities may be issued at a discount to market. No shares have been issued under this facility; it is authorization only, and the Board may decide not to use it. The same meeting includes a contested governance item: shareholder-nominated director candidate Param Lally, a self-nominated shareholder the Board assessed as independent, is on the ballot with the Board recommending shareholders vote AGAINST his election. The Board also seeks to renew its Omnibus Incentive Plan and lift the rolling three-year employee-securities cap from 5% to 12.5% of issued capital (about 40.4 million securities), which would keep equity compensation outside the 15% placement limit. For a company of this size, the combination of a fresh 10% issuance mandate and a contested board seat is the material story; the meeting is set for 18 November 2026.